A page in the reference notebook
Liraglutide
Also listed as: Saxenda
Keep the record, its references, and your reading question together.
- Product status
- Approved product
- Evidence label
- Randomized evidence
- Body topics
- Metabolism
Status as of
Reference fields
Read the fields together.
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limitations
- Check other products separately.
- Safety
- The label warns about severe gastrointestinal reactions.
- Route and product context
- Subcutaneous injection.
- Approval scope
- Saxenda: weight management for eligible patients.
A little room to think
One clearer reading question.
Before interpreting a total, identify what earns a place in the count. A person, an entry, and an occasion are different units. If the same contributor could appear more than once, counting entries would not establish how many distinct contributors were represented. That does not make the tally wrong; it changes what the tally answers. Rewrite the reported total in words that name its unit. If your question concerns a different unit, ask for the connection between them instead of assuming that the numbers can be used interchangeably.
Questions to keep nearby
- What exactly earns a separate place in the total being reported?
- Could the same contributor account for several entries in this count?
- What information would connect the reported unit to the unit my question needs?
Follow the record
Source list
- SAXENDA
NLM · Checked